key: cord-0879206-g47eu64p authors: Sule, Goncu Ayhan; Aysegul, Atalay; Selcan, Sinaci; Atakan, Tanacan; Eda, Ozden Tokalioglu; Deniz, Oluklu; Filiz, Halici Ozturk; Ozlem, Moraloglu Tekin; Dilek, Sahin title: Effects of SARS‐COV‐2 infection on fetal pulmonary artery Doppler parameters date: 2021-06-29 journal: Echocardiography DOI: 10.1111/echo.15146 sha: c28765f6806cd7f87d7246301dc8bd03507b97de doc_id: 879206 cord_uid: g47eu64p PURPOSE: To determine the effect of SARS‐CoV‐2 infection on the fetal pulmonary system using the acceleration time (AT), ejection time (ET), and acceleration/ejection time ratio (PATET) of the fetal main pulmonary artery Doppler waveform. METHODS: We prospectively studied pregnant women attending our hospital with confirmed SARS‐CoV‐2 infection by RT‐PCR test and an age‐matched control group who admitted for routine prenatal care. An ultrasound examination that included measurements of the AT, ET, and AT/ET ratio (PATET) were performed and the results were compared. RESULTS: Fifty‐five SARS‐CoV‐2‐infected and 93 control group pregnant women were included in this study. AT found higher in the COVID‐19 positive group when compared with controls. When the ET and PATET parameters were compared, no differences were detected between the groups. Eleven neonates had Neonatal Intensive Care Unit (NICU) requirement in the COVID‐19 positive group while there were none in the control group. All fetal pulmonary artery Doppler values were decreased in NICU admitted fetuses. The mean gestational week of this group was lower than non‐NICU COVID‐19 positive group and the control group. CONCLUSION: COVID‐19 infection increases fetal pulmonary blood flow, which appears high AT values on Doppler parameters. NICU admission only occurred in the COVID‐19 group and their Doppler values were found significantly lower than non‐NICU COVID‐19 group. The clinical significance of this result must be evaluated with further studies. Mann-Whitney U test. A type-1 error below .05 was considered statistically significant. Table 1 shows the demographic features of patients with COVID-19 (n = 55) and patients in the control group (n = 93). The two groups were homogenous, and no differences were noted in the demographic data. When the AT parameters were compared, the COVID-19 group displayed increased values compared to the controls. When the ET and PATET parameters were compared, no differences were detected between the groups. with a significant lengthening throughout gestation, and a significant increase in the PATET ratio. 13 Schenone et al. (2014) found increasing PATET values with increasing gestational age, which correlates with testing of fetal lung maturity by amniocentesis. 19 These data indicate that increases occur in 1) angiogenesis during fetal lung maturity, 2) wall elasticity of the pulmonary artery, and 3) blood flow, which suggests that AT reaches peak values during an extended time period. In another study, the AT values and PATET ratios were significantly lower in the RDS group than in the non-RDS group, even after control- Additionally, maternal hypoxia may lead to fetal hypoxia, and this is a stimulus for oxidative stress. 29 However, reports are inconsistent regarding lung maturation and respiratory outcomes following fetal hypoxemia in both clinical and animal studies. 30, 31 These inconsistencies may relate to assessment of the severity and duration of fetal hypoxemia. In our study, all COVID-19 patients were in the mild or moderate infection category and hypoxemia was not evident, offering one explanation for the findings of the present study. The presence of angiotensin-converting enzyme 2 (ACE2) on target cells is the key to SARS-CoV-2 entry. 32 With regard to fetal lung tissues, Goyal et al. showed significant overexpression of both ACE-2 mRNA and protein in fetal lungs as a consequence of maternal hypoxic stress; thus, we expected decreased fetal lung blood flow in infected pregnant women. 33 However, a recent study using immunocytochemistry analysis revealed that ACE2 was barely The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: a systematic review Updated experience of a tertiary pandemic center on 533 pregnant women with COVID-19 infection: a prospective cohort study from Turkey Maternal and neonatal characteristics and outcomes among COVID-19 infected women: an updated systematic review and meta-analysis Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn The fetal inflammatory response syndrome The fetal inflammatory response syndrome Changes in umbilical and cerebral blood flow in pregnancies diagnosed with clinical chorioamnionitis Prediction of neonatal respiratory distress syndrome via pulmonary artery Doppler examination Effect of betamethasone on fetal pulmonary and umbilical artery Doppler velocimetry and relationship with respiratory distress syndrome development Branch pulmonary artery Doppler parameters predict early survival-non-survival in premature rupture of membranes Doppler echocardiography of the main stems of the pulmonary arteries in the normal human fetus Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique The role of Doppler waveforms in the fetal main pulmonary artery in the prediction of neonatal respiratory distress syndrome Evaluation of the relationship between placental thickness and obstetric Doppler parameters during the second trimester Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Acceleration/ejection time ratio in the fetal pulmonary artery predicts fetal lung maturity Predicting fetal lung maturity using the fetal pulmonary artery Doppler wave acceleration/ejection time ratio Placental pathology in COVID-19 Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy The COVID-19 cytokine storm; what we know so far Coagulopathy in COVID-19 Cardiovascular implications of the COVID-19 pandemic: a global perspective Fetal inflammatory response syndrome associated with maternal SARS-CoV-2 infection Effects of intrauterine infection or inflammation on fetal lung development Intrauterine infection and preterm delivery Experimental intrauterine Ureaplasma infection in sheep Pathophysiology of persistent pulmonary hypertension of the newborn: impact of the perinatal environment Changes in surfactantassociated protein mRNA profile in growth-restricted fetal sheep Intrauterine growth restriction delays surfactant protein maturation in the sheep fetus SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Antenatal maternal hypoxic stress: adaptations in fetal lung Renin-Angiotensin system Anatomical and timely assessment of protein expression of angiotensin-converting enzyme 2, SARS-CoV-2 specific receptor, in fetal and placental tissues: new insight for perinatal counseling Maternal and neonatal outcomes associated with COVID-19 infection: a systematic review Vertical transmission of severe acute respiratory syndrome coronavirus 2: a systematic review Vertical transmission of coronavirus disease 19 (COVID-19) from infected pregnant mothers to neonates: a review Effects of SARS-COV-2 infection on fetal pulmonary artery Doppler parameters